Steven D. Gore, MD

Director of Hematologic Malignancies

Physician Biography

Dr. Gore came to Yale in November 2013 following 23 years on the faculty at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, Maryland. Dr. Gore is an international authority on myelodysplastic syndromes (MDS) and other forms of leukemia. He is particularly known for his novel clinical and translational trials in MDS and leukemia, using drugs which target epigenetic abnormalities in leukemia cells. He is a leader in the leukemia effort of the Eastern Cooperative Oncology Group and is a member of the MDS committee of the National Cancer Care Network.

Clinical Interests

  • Hematology
  • Medical Oncology

Patient Care

Accepts new patients? Yes
Patient Type: Adult
Referrals: From patients or physicians

Patient Care Organizations

Cancer Center, Yale: Hematology Program


Yale Medical Group

Clinical Trials

Conditions Study Title
Leukemia, other Ph I: ASP2215 in Combination With Induction and Consolidation Chemo in Pts With Newly Diagnosed AML
Hodgkin's Lymphoma, Leukemia, other, Multiple Myeloma, Non-Hodgkin's Lymphoma, Other Hematopoietic An Open-Label Study of a Novel JAK-inhibitor,INCB052793,Given to Patients With Advanced Malignancies
Leukemia, not otherwise specified, Leukemia, other, Myeloid and Monocytic Leukemia Phase 1 of IPI in Relapsed/Refractory High Risk MDS and AML
Myeloid and Monocytic Leukemia Ph 3: Randomized Study of Quizartinib v Salvage Chemo for FLT3-ITD Positive AML
Myeloid and Monocytic Leukemia Selinexor (KPT-330) in Older Patients With Relapsed AML (SOPRA)
Leukemia, other Randomized Phase III: BR vs Ibrutinib +R vs Ibrutinib Alone in Untreated Older Pts with CLL
Lymphoid Leukemia Ibrutinib+Rituximab v. Fludarabine Phosphate, Cyclophosphamide, and Rituximab in untreated CLL
Leukemia, not otherwise specified, Leukemia, other, Myeloid and Monocytic Leukemia, Other Hematopoietic Phase III Len vs Len + Epoetin Alfa for Low or Intermediate Risk MDS and Symptomatic Anemia (CIRB)
Leukemia, other E1910: Blinatumomab for Frontline BCR-ABL (-) B Cell ALL

Edit this profile

Contact Info

Steven D. Gore, MD
Patient Care Location
Yale Cancer Center-YNHHYale-New Haven Hospital
20 York Street, Ste 7th Floor

New Haven, CT 06510
View on map...
Mailing Address
25 York Street
PO Box 208028

New Haven, CT 06520-8028

Curriculum Vitae